Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 226,675,971 papers from all fields of science
Search
Sign In
Create Free Account
erythralosamine
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Broader (1)
Erythromycin
analogs & derivatives
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
Investigating the potential of erythromycin and derivatives as chiral selector in capillary electrophoresis.
Pham Thi Thanh Ha
,
A. Van Schepdael
,
E. Roets
,
J. Hoogmartens
Journal of Pharmaceutical and Biomedical Analysis
2004
Corpus ID: 19476625
1995
1995
Conformational change due to esterification of hydroxy groups in erythromycin A and its major metabolite: analysis of these derivatives with different biological properties using NMR and molecular…
P. Ladam
,
J. Gharbi-Benarous
,
M. Delaforge
,
M. Van Calsteren
,
C. Jankowski
,
J. Girault
Bioorganic & Medicinal Chemistry
1995
Corpus ID: 5755473
1989
1989
In vitro interaction of rat liver cytochromes P-450 with erythromycin, oleandomycin and erythralosamine derivatives. Importance of structural factors.
E. Sartori
,
M. Delaforge
,
D. Mansuy
Biochemical Pharmacology
1989
Corpus ID: 29901358
1985
1985
Some erythromycin derivatives are strong inducers in rats of a cytochrome P-450 very similar to that induced by 16 alpha-pregnenolone carbonitrile.
E. Sartori
,
M. Delaforge
,
D. Mansuy
,
P. Beaune
Biochemical and Biophysical Research…
1985
Corpus ID: 45391263
Highly Cited
1978
Highly Cited
1978
Fluorimetric determination of erythromycin and erythromycin ethylsuccinate in serum by a high-performance liquid chromatographic post-column, on-stream derivatization and extraction method.
K. Tsuji
Journal of Chromatography A
1978
Corpus ID: 13304129
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE